AEON Biopharma (AEON) Other Operating Expenses (2021 - 2026)
AEON Biopharma (AEON) posted Other Operating Expenses of $10000.0 for Q4 2025, up 127.03% sequentially from -$37000.0 in Q3 2025, and up 100.3% YoY from $4992.5 in Q4 2024.
AEON Biopharma (AEON) Other Operating Expenses (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Other Operating Expenses for 5 years, with the latest figure at $10000.0 in Q4 2025.
- Quarterly Other Operating Expenses rose 100.3% year-over-year to $10000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.5 million (up 96.53% YoY) and the FY2025 annual result came in at -$3.5 million, up 96.53% from the prior year.
- Other Operating Expenses climbed to $10000.0 in Q4 2025 per AEON's latest filing, from -$37000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $272.1 million in Q3 2023 and troughed at -$161.2 million in Q2 2024.
- A 5-year average of $12.2 million and a median of $294968.0 in 2021 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 100.3% in 2025, down 105.47% in 2025.
- Over 5 years, Other Operating Expenses stood at $885744.0 in 2021, then plunged by 51.77% to $427204.0 in 2022, then jumped by 63584.09% to $272.1 million in 2023, then sank by 101.23% to -$3.3 million in 2024, then jumped by 100.3% to $10000.0 in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $10000.0, -$37000.0, and $16000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | -3.49 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Jun 30, 2024 | -161.23 Mn |
| Mar 31, 2024 | 63.77 Mn |
| Sep 30, 2023 | 272.06 Mn |
| Jun 30, 2022 | 427,204.00 |
| Mar 31, 2022 | 389,073.00 |
| Dec 31, 2021 | 885,744.00 |
| Sep 30, 2021 | 450,892.00 |
| Jun 30, 2021 | 398,443.00 |
| Mar 31, 2021 | 200,863.00 |